• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC TO-I/A filed by Assure Holdings Corp.

    9/24/24 6:07:31 AM ET
    $IONM
    Medical/Dental Instruments
    Health Care
    Get the next $IONM alert in real time by email
    SC TO-I/A 1 tm2424532d2_sctoia.htm SC TO-I/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE TO

    (Amendment No. 10)

    Tender Offer Statement Under Section 13(e)(1)

    of the Securities Exchange Act of 1934

     

    ASSURE HOLDINGS CORP.

    (Name of Subject Company (Issuer) and Filing Person (Offeror))

     

    9% CONVERTIBLE DEBENTURES DUE 2023 AND 2024

    (Title of Class of Securities)

     

    04625J303

    (CUSIP Number of Common Stock Underlying Debentures)

     

    John Farlinger

    Executive Chairman and Chief Executive Officer

    7887 East Belleview Avenue, Suite 1100

    Denver, Colorado 80111

    Telephone: 720-287-3093

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person)
     
     
    Copies to:
     

    Jason K Brenkert, Esq.

    Dorsey & Whitney LLP

    1400 Wewatta Street, Suite 400

    Denver, Colorado 80202

    Telephone: (303) 352-1133

    Fax Number: (303) 629-3450

     

     

    ¨ Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

     

    Check the appropriate boxes below to designate any transactions to which the statement relates:

     

    ¨ third party tender offer subject to Rule 14d-1.
    x issuer tender offer subject to Rule 13e-4. 
    ¨ going-private transaction subject to Rule 13e-3.
    ¨ amendment to Schedule 13D under Rule 13d-2.

     

    Check the following box if the filing is a final amendment reporting the results of the tender offer: x

     

    If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

     

    ¨ Rule 13e-4(i) (Cross-Border Issuer Tender Offer)
    ¨ Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)

     

     

     

     

     

    INTRODUCTORY STATEMENT

     

    This Amendment No. 10 (“Amendment No. 10”) amends the Tender Offer Statement on Schedule TO originally filed by Assure Holdings Corp., a Nevada corporation (the “Company”, “we”, “us” or “our”), on June 21, 2024, as amended on July 3, 2024, July 9, 2024, July 12, 2024, July 22, 2024, July 30, 2024, August 6, 2024, August 20, 2024, August 26, 2024 and September 9, 2024 (as amended through September 9, 2024, the “Ninth Amended Schedule TO”),  in connection with an offer, as amended (the “Convertible Note Exchange Offer”), by Assure to exchange, for each $1,000 claim, consisting of principal amount, and accrued and unpaid interest through, and including, September 20, 2024, of the Company’s 9% Convertible Debentures due 2023 and 2024 (the “Assure Convertible Debentures”), 1,000 shares of the Company’s common stock (the “Common Stock”) equal to the quotient of $1,000 divided by a per share price of $1.00.

     

    This Amendment No. 10 is being filed solely to amend “Item 11 - Additional Information” to reflect and report the final results of the Convertible Note Exchange Offer. This Amendment No. 10 is intended to satisfy the disclosure requirements of Rule 13e-4(c)(4) under the Securities Exchange Act of 1934, as amended. Except as specifically set forth herein, this Amendment No. 10 does not modify any of the information previously reported in the Ninth Amended Schedule TO.

     

    Item 11. Additional Information

     

    Item 11 of the Ninth Amended Schedule TO is hereby amended and supplemented by adding the following:

     

    The Convertible Note Exchange Offer expired at 11:59 p.m. (Denver time) on September 20, 2024 (the “Expiration Time’).

      

    $2,129,000 in principal amount of Assure Convertible Debentures were validly tendered and not withdrawn pursuant to the Convertible Note Exchange Offer.

     

    Promptly following the Expiration Time, the Company accepted for exchange $2,129,000 in principal amount of Assure Convertible Debentures validly tendered and not withdrawn pursuant to the terms of the Convertible Note Exchange Offer and promptly issued 2,477,082 shares of Common Stock in exchange for the tendered and accepted Assure Convertible Notes, and including an additional $348,093 in accrued and unpaid interest through, and including, September 20, 2024, in relation to such tendered and accepted Assure Convertible Notes and will pay $11 in cash in settlement of fractional shares of Common Stock issuable pursuant to the Convertible Note Exchange Offer.

     

    Item 12. Exhibits.

     

      (a) (1) (i)* Offer Letter dated June 21, 2024
          (ii)* Amendment No. 1 to Offer Letter dated July 3, 2024
          (iii)* Amendment No. 2 to Offer Letter dated July 12, 2024
          (iv)* Amendment No. 3 to Offer Letter dated July 30, 2024
          (v)* Amendment No. 4 to Offer Letter dated September 9, 2024
          (vi)* Amended Letter of Transmittal dated July 3, 2024
          (vii)* Withdrawal  Form
          (viii)* Form of Confirmation email/letter to Holders who Elect to Participate in the Offer
          (ix)* Form of Cover Letter to Holders
          (x)* Letter to Holders dated July 9, 2024
          (xi)* Press Release dated July 22, 2024
          (xii)* Press Release dated July 29, 2024
          (xiii)* Press Release dated August 5, 2024
          (xiv)* Press Release dated August 19, 2024

     

     

     

     

          (xv)* Press Release dated August 26, 2024
          (xvi)* Press Release dated September 9, 2024
          (xvii) Form 8-K dated September 23, 2024
      (b) Not applicable
      (d) (1) (i) Form of Convertible Debenture (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1 as filed on December 30, 2020)
      (g) Not applicable
      (h) Not applicable
      107 Filing Fees*

     

    * - Previously filed

     

     

     

     

    SIGNATURES

     

    After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      ASSURE HOLDINGS CORP.  
         
    By: /s/ John Farlinger  
      John Farlinger  
      Chief Executive Officer  

     

    Dated: September 23, 2024

     

     

     

     

    INDEX TO EXHIBITS

     

      (a) (1) (i)* Offer Letter dated June 21, 2024
          (ii)* Amendment No. 1 to Offer Letter dated July 3, 2024
          (iii)* Amendment No. 2 to Offer Letter dated July 12, 2024
          (iv)* Amendment No. 3 to Offer Letter dated July 30, 2024
          (v)* Amendment No. 4 to Offer Letter dated September 9, 2024
          (vi)* Amended Letter of Transmittal dated July 3, 2024
          (vii)* Withdrawal  Form
          (viii)* Form of Confirmation email/letter to Holders who Elect to Participate in the Offer
          (ix)* Form of Cover Letter to Holders
          (x)* Letter to Holders dated July 9, 2024
          (xi)* Press Release dated July 22, 2024
          (xii)* Press Release dated July 29, 2024
          (xiii)* Press Release dated August 5, 2024
          (xiv)* Press Release dated August 19, 2024
          (xv)* Press Release dated August 26, 2024
          (xvi)* Press Release dated September 9, 2024
          (xvii) Form 8-K dated September 23, 2024
      (b) Not applicable
      (d) (1) (i) Form of Convertible Debenture (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1 as filed on December 30, 2020)
      (g) Not applicable
      (h) Not applicable
      107 Filing Fees*

     

    * - Previously filed

     

     

     

    Get the next $IONM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IONM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IONM
    Leadership Updates

    Live Leadership Updates

    See more
    • Assure Holdings Announces Results of Annual General Meeting of Shareholders

      DENVER, Dec. 30, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that it held its annual general meeting of shareholders on December 28, 2022 (the "Meeting") and that all matters submitted to the shareholders of the Company for approval as set out in the Company's definitive proxy statement dated December 2, 2022 (the "Proxy Statement"), were approved by the requisite majority of votes cast at the Meeting, including: Electing the following nominees to the board of directors of the Company to serve until the Company's next annual general meeting of

      12/30/22 4:02:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Further Strengthens Business Development Team with Hiring of Robynn Sweet as Vice President, Strategic Accounts

      DENVER, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of Robynn Sweet to the position of vice president, strategic accounts. Prior to joining Assure, Ms. Sweet worked at Premier, Inc. serving as director of Group Purchasing Organization ("GPO") sales for national accounts. Before that, Ms. Sweet was regional vice president of sales at HealthTrust where her efforts were instrumental in driving more than $100 million in corporate revenue. Ms. Sweet earned a Bachelor of Science in Nursing from the University of Texas Health Scienc

      8/23/22 4:30:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Further Strengthens Clinical Team with Hiring of James Watt as National Technologist Director

      DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced the appointment of James Watt to the position of national technologist director. Mr. Watt reports to Assure's vice president of clinical operations, Stephanie Krouse. In his new role, Mr. Watt leads day-to-day operations for Assure's clinical technologist team, ensuring quality of service and overseeing the Company's training and development program. In addition, Mr. Watt will play an important role in the establishment of new competencies that will drive Assure's expansion into adjacent m

      4/26/22 8:30:00 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    SEC Filings

    See more
    • Assure Holdings Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - Assure Holdings Corp. (0001798270) (Filer)

      1/22/25 4:00:28 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Assure Holdings Corp. (0001798270) (Filer)

      12/23/24 4:01:32 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form NT 10-Q filed by Assure Holdings Corp.

      NT 10-Q - Assure Holdings Corp. (0001798270) (Filer)

      11/15/24 7:19:43 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

      SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

      2/9/24 10:14:47 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

      SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

      2/10/23 3:08:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by Assure Holdings Corp. (Amendment)

      SC 13G/A - Assure Holdings Corp. (0001798270) (Subject)

      1/10/23 4:45:27 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Parsons Preston T

      4 - Assure Holdings Corp. (0001798270) (Issuer)

      4/13/23 8:43:47 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Burian Martin Andrew

      4 - Assure Holdings Corp. (0001798270) (Issuer)

      4/10/23 7:31:27 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Parsons Preston T

      4 - Assure Holdings Corp. (0001798270) (Issuer)

      4/10/23 4:41:09 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    Financials

    Live finance-specific insights

    See more
    • Assure & Danam Reschedule Corporate Update Call & Webcast

      DENVER, May 17, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management has rescheduled the joint corporate update call with Danam for Wednesday, May 22, 2024 at 4:00 PM Eastern Time. Conference Call InformationDate: Wednesday, May 22, 2024Time: 4:00 PM Eastern TimeToll Free: 1-877-545-0523International: 1-973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free:   1-877-481-4010International: 1-919-882-2331Replay Passcode: 50637Webcast Replay: h

      5/17/24 2:04:20 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure & Danam Postpone Corporate Update Call & Webcast Scheduled for May 16

      DENVER, May 15, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that the joint corporate update call with Danam scheduled for Thursday, May 16, 2024 at 4 p.m. Eastern Time has been postponed. The Company plans to reschedule the conference call at a later date. About Assure Holdings Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive proc

      5/15/24 8:50:44 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure & Danam to Host Corporate Update Call & Webcast

      DENVER, May 13, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the "Company" or "Assure") (NASDAQ:IONM), a provider of intraoperative neuromonitoring ("IONM") and remote neurology services, announced today that management will host a joint corporate update call with Danam on Thursday, May 16, 2024 at 4:00 PM Eastern Time to provide a corporate update. Conference Call InformationDate: Thursday, May 16, 2024Time: 4:00 PM Eastern TimeToll Free: 877-545-0523International: 973-528-0016Participant Access Code: 229289Webcast Link: https://www.webcaster4.com/Webcast/Page/2566/50637 Conference Call Replay InformationToll Free: 877-481-4010International: 919-882-2331Replay Passcode: 50637Webc

      5/13/24 4:01:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care

    $IONM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Assure Announces Amendment of Exchange Offer Relating to its Convertible Notes

      Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has amended the Convertible Note Exchange Offer of June 21, 2024, relating to the Company's 9% Convertible Debentures due in 2023 and 2024 (the "Assure Convertible Debentures"). This ninth amendment further amends and restates certain sections of the Convertible Note Exchange Offer ("Amended Offer Letter") as follows: (i) updates the Amended Offer Letter to reflect a change in the consideration being offered for each $1,000 claim from 238.44 shares of common stock consisting of principal amount, and accrued and unpaid interest through, and including, July 19, 2024 to 1,000 shares of common stock consisting

      9/6/24 8:45:00 PM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

      DENVER, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on September 6, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on September 6, 2024. Except for the extension

      8/26/24 8:00:00 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care
    • Assure Announces Further Extension of Exchange Offer Relating to its Convertible Notes

      DENVER, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. ("Assure" or the "Company") (OTC:IONM), today announced that it has extended the expiration date of its exchange offer (the "Offer") relating to the Company's 9% Convertible Debentures due 2023 and 2024 (the "Assure Convertible Debentures"). As a result of the extension, the Exchange Offer is now scheduled to expire at 11:59 p.m. (Denver Time), on August 23, 2024 (the "Expiration Date") unless further extended. The Offer was originally scheduled to expire at 11:59 p.m. (Denver Time) on July 19, 2024, and has been extended several times to now expire at 11:59 p.m. (Denver Time), on August 23, 2024. Except for the extension of

      8/19/24 8:00:00 AM ET
      $IONM
      Medical/Dental Instruments
      Health Care